Learn how the Defense Advanced Research Projects Agency (DARPA) has spurred significant advances in the promising field of synthetic biology.
Benjamin Wolfson is a Ph.D. Candidate in molecular medicine at the University of Maryland, Baltimore, focusing on noncoding RNAs in the breast cancer microenvironment. Outside the lab, he is passionate about the impact of policy on science, and the roles that science and technology play in society and creating the future. Find more of his writing at www.benwolfson.com or on Twitter @brwolfson.